Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma

Erasmus Medical Center, Rotterdam0 个研究点目标入组 20 人开始时间: 待定最近更新: 2024年2月28日

试验速览

阶段: 不适用
状态: 招募中
发起方
入组人数: 20

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

de Boer NL, van Kooten JP, Burger JWA, Verhoef C, Aerts J, Madsen EVE. Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial. BMJ Open. 2019;9(5):e026779. van Kooten JP, de Boer NL, Burger JWA, Verhoef C, Aerts J, Madsen EVE. Adjuvante Dendritische Cel Immunotherapie na Cytoreductieve Chirurgie en Hypertherme Intraperitoneale Chemotherapie voor patiënten met Maligne Peritoneaal Mesothelioom. De MESOPEC studie. Nederlands Tijdschrift voor Oncologie. Jaargang 16, Nummer 2, Maart 2019.

研究设计

研究类型: Interventional

入排标准

入选标准

•In order to be eligible to participate in this study, a subject must meet all of the following criteria, before undergoing CRS-HIPEC:
•Patients with a histologically or cytologically confirmed diagnosis of malignant peritoneal mesothelioma

排除标准

•A potential participant who meets any of the following criteria will be excluded from participation in the study:
•Extra-abdominal disease/ metastatic disease

研究者

发起方

Erasmus Medical Center, Rotterdam

相似试验

已完成

2 期

Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesotheliomaasbestos cancerperitoneal mesenthelioma10027412

NL-OMON48572Erasmus MC, Universitair Medisch Centrum Rotterdam18

进行中（未招募）

1 期

Personalized dendritic cell-based immune therapy for improving treatment of children with brain (stem) tumorsChildhood high-grade glioma and diffuse intrinsic pontine gliomaMedDRA version: 20.0Level: LLTClassification code 10046859Term: VaccinationSystem Organ Class: 100000004865MedDRA version: 20.0Level: PTClassification code 10006143Term: Brain stem gliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10080666Term: Diffuse intrinsic pontine gliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)

EUCTR2020-004125-23-BEAntwerp University Hospital10

进行中（未招募）

1 期

Dendritic cell-based immunotherapy for advanced solid tumours of children and young adultsChildren and young adults with advanced solid tumours: relapsed or metastatic sarcomas or central nervous system tumours.

EUCTR2013-003632-71-ESClínica Universidad de Navarra/Universidad de Navarra10

尚未招募

1 期

Therapeutic Vaccine Based on aDC1 Dendritic Cells for the Control of Viremia After ATI in HIV Infected IndividualsHIV Vaccine

NCT05786937University of Sao Paulo General Hospital30

尚未招募

不适用

Dendritic cell-based immunotherapy combined with low-dose cyclophosphamide in patients with malignant pleural mesotheliomamesothelioma10035597

NL-OMON32554Erasmus MC, Universitair Medisch Centrum Rotterdam10